Characterization of Alisertib (MLN8237), an Investigational Small-Molecule Inhibitor of Aurora A Kinase Using Novel In Vivo Pharmacodynamic Assays (Q39455013)
Jump to navigation
Jump to search
scientific article published on October 20, 2011
Language | Label | Description | Also known as |
---|---|---|---|
English | Characterization of Alisertib (MLN8237), an Investigational Small-Molecule Inhibitor of Aurora A Kinase Using Novel In Vivo Pharmacodynamic Assays |
scientific article published on October 20, 2011 |
Statements
1 reference
Characterization of Alisertib (MLN8237), an investigational small-molecule inhibitor of aurora A kinase using novel in vivo pharmacodynamic assays (English)
1 reference
Characterization of Alisertib (MLN8237), an Investigational Small-Molecule Inhibitor of Aurora A Kinase Using Novel In Vivo Pharmacodynamic Assays (English)
1 reference
Arijit Chakravarty
1 reference
Lee Silverman
1 reference
Mengkun Zhang
1 reference
Wei Chen
1 reference
Vaishali Shinde
1 reference
Mark G. Manfredi
Jeffrey A. Ecsedy
Kara M. Hoar
Stephen G. Stroud
Jessica J. Huck
Deborah R. Wysong
David A. Janowick
Marc L. Hyer
Patrick J. Leroy
Rachel E. Gershman
Matthew D. Silva
Melissa S. Germanos
Joseph B. Bolen
Christopher F. Claiborne
Todd B. Sells
20 October 2011
1 reference
1 reference
17
1 reference
24
1 reference
7614-7624
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference